सोमवार, 27 मई 2019

thumbnail

Granules India receives final approval for ADHD treatment drug from USFDA

The approved product is bioequivalent to the reference listed drug product (RLD), Ritalin LA extended-release capsules of Novartis Pharmaceuticals Corporation.

from Latest News http://bit.ly/2HG251j

Related Posts :

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

About

ब्लॉग आर्काइव

Blogger द्वारा संचालित.